Aspergillosis, the leading fungal cause of mortality in immunocompromised patients, presents a serious worldwide challenge--particularly in the face of increasing antifungal resistance. Bringing together the world's leaders in the Aspergillus and aspergillosis fields to promote cross-disciplinary collaboration among clinicians, industry, and scientific experts, the -Advances Against Aspergillosis- conference was held January 26-28, 2012 in Istanbul, Turkey.

This second of two Annals volumes contains short reviews encapsulating recent findings in the basic science of...